US Edition
News from verdenews.com
We’ve assigned a rating of Unknown factuality to verdenews.com. You can read more about how we’ve determined verdenews.com’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top verdenews.com News
Movies & TV · Los AngelesThe son of famed director Rob Reiner is in custody of the Los Angeles County Sheriff's Department after Reiner and his wife, Michele Singer, were found dead in their L.A. home on Sunday.See the Story
Rob Reiner's son arrested after famed director, wife found stabbed to death in LA home
51% Center coverage: 490 sources
Los Angeles, California · Los AngelesLOS ANGELES, Dec. 16, 2025 /PRNewswire/ -- Today, the MARRIAGETOXIN Project announced the release of an all-new main visual, first trailer, and additional main staff for the highly anticipated hitman x marriage swindler, battle-action series, MARRIAGETOXIN. The anime adaptation from BONES Film, known for My Hero Academia and Gachiakuta, welcomes Anna Nagase, Mariya Ise, Asaki Yuikawa, Soma Saito, Hinano Shirahama, and Simba Tsuchiya into its cas…See the Story
MARRIAGETOXIN Ties the Knot on New Visuals, First ...
90% Center coverage: 20 sources
San Francisco, California · San FranciscoSAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first patient has been dosed for one of its key oversea clinical studies:…See the Story
Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases
83% Center coverage: 18 sources
